This video dives into a rare showcase of exclusive machines that celebrate pure driving emotion without compromise. It ...

The investigational KRAS G12D inhibitor zoldonrasib showed evidence of clinical activity and a favorable safety profile in ...

Clinical trials of therapies for metabolic dysfunction-associated steatohepatitis (MASH) cirrhosis suffer from a lack of ...

Within the expanding domain of short-chain bioactive peptides, Decapeptide-12 has emerged as a particularly intriguing molecular construct.

Perfectionism often impedes the creative process. However, an awareness of the two types of perfectionism can open up ...

EO1001 demonstrates up to ~40-fold greater potency than osimertinib in EGFR ECD-mutant tumor models EO4426 (tezacitabine) demonstrates selective targeting of DNA replication machinery and resistance ...

We recently compiled a list of the 8 Oversold Biotech Stocks to Invest In Now. Cadrenal Therapeutics, Inc. is among the ...

Merck and Eisai provide update on phase 3 LITESPARK-012 trial evaluating first-line combination treatments for certain patients with advanced RCC: Rahway, New Jersey Wednesday, Ap ...

TheFly reported on April 7 that H.C. Wainwright reduced its price target on CVKD from $32 to $13 while maintaining a Buy ...

Cytokinetics is valued at ~$8.1B, reflecting high expectations post MYQORZO oHCM launch, despite limited commercial data. See ...

Regeneron reached an agreement with the U.S. government to link current and future drug prices to those in other developed ...

The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts. By Angelica P ...